NOVAVAX INC Cash And Cash Equivalents At Carrying Value

• NOVAVAX INC showed a decrease of -54.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from NOVAVAX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: $9.45 million | Q3 2010: $16.22 million | Q1 2011: $8.36 million | Q2 2011: $13.09 million | Q3 2011: $14.32 million | Q1 2012: $13.87 million | Q2 2012: $15.33 million | Q3 2012: $10.74 million | Q1 2013: $9.02 million | Q2 2013: $2.57 million | Q3 2013: $122.49 million | Q1 2014: $109.92 million | Q2 2014: $103.86 million | Q3 2014: $34.47 million | Q1 2015: $215.05 million | Q2 2015: $167.38 million | Q3 2015: $138.14 million | Q1 2016: $132.23 million | Q2 2016: $89.40 million | Q3 2016: $119.95 million | Q1 2017: $95.85 million | Q2 2017: $75.79 million | Q3 2017: $104.25 million | Q1 2018: $113.40 million | Q2 2018: $88.48 million | Q3 2018: $56.50 million | Q1 2019: $97.71 million | Q2 2019: $72.00 million | Q3 2019: $71.17 million | Q1 2020: $179.88 million | Q2 2020: $424.40 million | Q3 2020: $334.17 million | Q1 2021: $2.00 billion | Q2 2021: $2.07 billion | Q3 2021: $1.94 billion | Q1 2022: $1.57 billion | Q2 2022: $1.38 billion | Q3 2022: $1.28 billion | Q1 2023: $624.95 million | Q2 2023: $505.91 million | Q3 2023: $651.10 million | Q1 2024: $480.59 million | Q2 2024: $680.16 million | Q3 2024: $573.63 million | Q1 2025: $263.34 million | Q2 2025: $253.74 million | Q3 2025: $268.02 million.
• Over the full 18 years of available data (2008 to 2025), NOVAVAX INC's Cash And Cash Equivalents At Carrying Value has grown by 793.3%.
• Historical annual values: Fiscal year 2025: $240.63 million | Fiscal year 2024: $530.23 million | Fiscal year 2023: $568.51 million | Fiscal year 2022: $1.34 billion | Fiscal year 2021: $1.52 billion | Fiscal year 2020: $553.40 million | Fiscal year 2019: $78.82 million | Fiscal year 2018: $70.15 million | Fiscal year 2017: $106.31 million | Fiscal year 2016: $144.35 million | Fiscal year 2015: $93.11 million | Fiscal year 2014: $32.34 million | Fiscal year 2013: $119.47 million | Fiscal year 2012: $17.40 million | Fiscal year 2011: $14.10 million | Fiscal year 2010: $8.06 million | Fiscal year 2009: $38.76 million | Fiscal year 2008: $26.94 million.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026